Close Menu

NEW YORK – Agilent Technologies announced that it is withdrawing its second-quarter and fiscal year 2020 guidance due to the global impact of COVID-19 on its business activities.

While the firm's Q2 revenues rose 2 percent through March, it noted a significant disruption in business activity in late March, especially in the US and Europe, as customers closed or restricted access to their facilities in an attempt to slow the spread of the coronavirus.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.

Science reports that Science Foundation Ireland is seeking annual budget increases.

According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.

In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.